PanOph

Floppy Iris Syndrome

Cataract & Refractive SurgeryIntraoperative TriadHigh YieldAlso: Intraoperative Floppy Iris Syndrome, IFIS

Key Points

  • •IFIS is defined by an intraoperative triad: billowing iris, iris prolapse toward incisions, and progressive miosis during cataract surgery.
  • •Tamsulosin (Flomax) is the most strongly associated drug — 57-100% of tamsulosin-treated patients show at least one IFIS sign; always ask about current or PAST alpha-1 blocker use.
  • •Stopping tamsulosin before surgery does NOT reliably prevent IFIS because the drug causes irreversible structural atrophy of the iris dilator muscle.
  • •Mechanical pupil expansion devices (iris hooks, Malyugin ring) combined with intracameral epinephrine and highly cohesive OVDs are the mainstay of intraoperative management.
  • •If a patient has not yet started tamsulosin but needs cataract surgery, advise performing cataract surgery FIRST before initiating the alpha-blocker.

Hallmark Features(Intraoperative Triad)

1

Billowing and undulating iris stroma

2

Iris prolapse toward phaco/side-port incisions

3

Progressive intraoperative miosis

4

Strong association with tamsulosin (Flomax)

Finder Clues

Billowing/undulating iris stromaIris prolapse toward incisionsProgressive intraoperative miosisPoor preoperative mydriasisFlaccid iris stroma with loss of rigidityIncreased risk of posterior capsule rupture
1. Definition

Intraoperative Floppy Iris Syndrome (IFIS) is an intraoperative complication of cataract surgery characterized by a triad of billowing iris stroma, iris prolapse toward surgical incisions, and progressive pupillary constriction during phacoemulsification. First described by Chang and Campbell in 2005, it is strongly associated with the use of tamsulosin (Flomax), a selective alpha-1A adrenergic receptor antagonist used to treat benign prostatic hyperplasia (BPH).

3. Pathogenesis

Mechanism of iris floppy behavior:

  • Tamsulosin is a selective alpha-1A adrenergic receptor blocker
  • Alpha-1A receptors are present on the iris dilator smooth muscle
  • Chronic blockade causes atrophy of the iris dilator muscle and loss of iris stromal rigidity
  • The iris becomes flaccid, losing its normal tone and structural support

Why effects persist after drug discontinuation:

  • Tamsulosin causes irreversible structural changes in the iris dilator muscle
  • Even after stopping the drug for months or years, the iris remains atrophic and floppy
  • This is why stopping tamsulosin preoperatively does not reliably prevent IFIS

Drug associations (in order of risk):

  • Tamsulosin (Flomax) — highest risk (57-100% of patients show at least one IFIS sign)
  • Silodosin — similar high risk (also selective alpha-1A blocker)
  • Alfuzosin, terazosin, doxazosin — lower risk (non-selective alpha-1 blockers)
  • Finasteride — very low risk (5-alpha reductase inhibitor, not alpha-blocker)
  • Mirabegron, antipsychotics (risperidone, paliperidone) — occasional reports
4. Clinical Features

Intraoperative triad (all three are not always present):

  1. Billowing iris stroma — the iris undulates and flutters with normal irrigation currents, appearing like a sheet in the wind
  2. Iris prolapse — the flaccid iris prolapses through phaco and side-port incisions despite proper wound construction
  3. Progressive miosis — the pupil constricts progressively during surgery despite adequate preoperative dilation, making visualization and phacoemulsification difficult

Preoperative clues:

  • Poor pharmacological dilation despite cyclopentolate and phenylephrine
  • History of tamsulosin or other alpha-1 blocker use (current or past)
  • Poorly dilating pupil (<6mm) should trigger suspicion

Complications of unmanaged IFIS:

  • Iris trauma (sphincter tears, iris chafing)
  • Posterior capsule rupture with vitreous loss
  • Retained lens fragments
  • Iridodialysis
  • Increased surgical time and postoperative inflammation
5. Ocular Manifestations

Iris changes:

  • Loss of iris stromal rigidity — the iris has a characteristic limp, floppy quality
  • Iris dilator muscle atrophy — histologically confirmed in tamsulosin-exposed irises
  • The iris may appear thinner than normal on UBM/AS-OCT

Pupil:

  • Poor preoperative dilation — failure to dilate beyond 5-6mm despite maximal pharmacological mydriasis
  • Rapid intraoperative constriction even after intracameral mydriatic use
  • Pupil may become extremely small (<3mm) during surgery

Surgical field effects:

  • Billowing iris encroaches on the phaco tip
  • Iris tissue aspirated into the phaco needle
  • Incision sites become foci for iris prolapse

Postoperative (if complications occur):

  • Iris sphincter tears — irregular pupil
  • Iris transillumination defects
  • Posterior capsule rupture — aphakia, vitreous loss, possible retinal detachment
  • Increased postoperative inflammation and CME risk
7. Diagnosis

Primarily a clinical (intraoperative) diagnosis:

Preoperative assessment — critical questions:

  • Always ask about current or past use of tamsulosin or any alpha-1 blocker before cataract surgery
  • Ask about BPH medications even if not currently taking them (effects are irreversible)
  • Note pupil dilation response to standard mydriatics

Grading (Chang IFIS grading):

  • Mild — iris billowing only, no prolapse, mild miosis
  • Moderate — iris billowing + prolapse or significant miosis
  • Severe — all three features: billowing + prolapse + progressive severe miosis

Pre-surgical evaluation:

  • Assess maximum pharmacological dilation with cyclopentolate + phenylephrine + tropicamide
  • If pupil dilates poorly (<6mm), plan for mechanical dilation devices
  • Review complete medication list, including past medications
8. Differential Diagnosis

Differential for intraoperative iris complications:

  • Small pupil syndrome (non-IFIS) — small pupil due to posterior synechiae, pseudoexfoliation, or chronic miotic use; iris is rigid (not floppy); mechanical dilation still needed but iris does not billow
  • Pseudoexfoliation syndrome — poor dilation, zonular weakness (risk of lens subluxation), but iris is not characteristically floppy
  • Chronic miotic use (pilocarpine) — small pupil, iris sphincter spasm; improve with atropine pretreatment
  • Iris neovascularization — rubeosis iridis from diabetic retinopathy or CRVO; iris bleeds easily during manipulation
9. Management

Preoperative preparation:

  • Stopping tamsulosin before surgery is NOT reliably effective due to irreversible iris changes — however, if the patient has not yet started tamsulosin, delay initiation until after cataract surgery if possible
  • Preoperative atropine 1% TID for 1-3 days before surgery — limited effectiveness (>50% still need further intervention)

Intraoperative management:

Pharmacological:

  • Intracameral epinephrine (1:10,000 or preservative-free 1:100,000) — helps maintain mydriasis
  • Intracameral phenylephrine — assists with pupil dilation
  • Use of highly cohesive OVDs (Healon5, DisCoVisc) — provides mechanical support to the iris and maintains the pupil ("OVD-shell technique")

Mechanical pupil expansion:

  • Iris retractors (4-point hooks) — most reliable method; placed at 4 quadrants to mechanically hold the pupil open
  • Malyugin ring — provides excellent pupil dilation with less iris manipulation than hooks

Surgical technique modifications:

  • Low flow rates and bottle height to reduce iris billowing
  • Smaller incisions to reduce iris prolapse risk
  • Avoid hydrodissection through a small pupil
  • Gentle, controlled phaco technique

If iris prolapse occurs:

  • Gently reposit iris with OVD
  • Do not cut prolapsed iris — this worsens the floppy behavior
  • Place iris retractors or ring if not already in use
10. Prognosis

With proper preparation — excellent:

  • When IFIS is anticipated and managed proactively, surgical outcomes are comparable to standard cases
  • Mechanical dilation devices (hooks, Malyugin ring) effectively mitigate all three IFIS features

Without preparation — increased complication risk:

  • Unanticipated IFIS leads to significantly higher rates of:
  • Posterior capsule rupture (2-5 times higher)
  • Vitreous loss
  • Iris trauma and irregular pupil
  • Prolonged surgical time

Key prognostic factor:

  • The most important prognostic factor is awareness — recognizing the risk preoperatively and having a management plan in place
  • IFIS effects do not diminish over time even years after stopping tamsulosin

Clinical Pearls

1

The single most important step in managing IFIS is preoperative identification — always ask 'Have you ever taken medication for your prostate?' before any cataract surgery, including past use.

2

Poorly dilating pupil (<6mm) with standard mydriatics in a male patient over 50 should trigger a specific medication inquiry even if not volunteered by the patient.

3

Highly cohesive OVDs (Healon5) can be used to viscomydriasis — inject under the iris to mechanically dilate the pupil and provide a physical barrier, but this alone may be insufficient in severe IFIS.

4

IFIS has been reported with other medications besides alpha-1 blockers, including antipsychotics (risperidone, paliperidone) and even in patients with no identifiable drug exposure — always be prepared.

Mnemonics

IFIS Triad — BPM

B—Billowing iris stroma

P—Prolapse of iris through incisions

M—Miosis (progressive intraoperative)

The three intraoperative hallmarks of floppy iris syndrome

IFIS Management — SOME

S—Small incisions (reduce prolapse risk)

O—OVD viscoadaptive/cohesive (Healon5)

M—Mechanical dilation (iris hooks, Malyugin ring)

E—Epinephrine intracameral (maintain mydriasis)

Intraoperative management strategy for IFIS

Alpha-1 Blockers by IFIS Risk

HIGH: Tamsulosin, Silodosin (selective alpha-1A)

MODERATE: Alfuzosin, Doxazosin, Terazosin (non-selective alpha-1)

LOW: Finasteride (not an alpha-blocker—5-alpha reductase inhibitor)

Relative risk of IFIS by BPH medication class

References

  1. paperIntraoperative Floppy Iris Syndrome Associated with Tamsulosin— Journal of Cataract and Refractive Surgery (2005)
  2. guidelineManaging Intraoperative Floppy Iris Syndrome— EyeNet, American Academy of Ophthalmology (2023)
  3. paperIntraoperative Floppy Iris Syndrome Induced by Tamsulosin: The Risk and Preventive Strategies— Risk Management and Healthcare Policy (2021)
  4. textbookKanski's Clinical Ophthalmology: A Systematic Approach— Elsevier (2020)
  5. paperRisk of Intraoperative Floppy Iris Syndrome Among Selective Alpha-1 Blockers— Frontiers in Medicine (2022)
Was this helpful?
Next →Homocystinuria